Kane LE, Mellotte GS, Mylod E, O'Brien RM, O'Connell F, Buckley CE, Arlow J, Nguyen K, Mockler D, Meade AD, Ryan BM, Maher SG, Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: A systematic review and meta-analysis, Gastroenterology, 2022,
Journal Article,
SUBMITTED
|
McGrath J, Kane LE, Lowery ME, Maher SG, The influence of microRNA-31 on oxidative stress and radiosensitivity in pancreatic ductal adenocarcinoma, International Journal of Molecular Sciences, 2022,
Journal Article,
SUBMITTED
|
Davern M, Fitzgerald MC, Buckley CE, Heeran AB, Donlon NE, McGrath J, O'Connell F, Deshpande MR, Hayes C, MacDonald J, Sheppard AD, Reynolds JV, Maher SG, Lynam-Lennon N, Murphy B, Lysaght J, PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours, Cancer Letters, 2022,
Journal Article,
SUBMITTED
|
Mylod E, McKenna E, Davern M, Barr MP, Donlon NE, Bibby BA, Bhardwaj A, Reynolds JV, Lysaght J, Maher SG, Conroy MJ., Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses, Clinical and Experimental Medicine, 2022,
Journal Article,
ACCEPTED
|
Davern, M. and Oâ Brien, R.M. and McGrath, J. and Donlon, N.E. and Melo, A.M. and Buckley, C.E. and Sheppard, A.D. and Reynolds, J.V. and Lynam-Lennon, N. and Maher, S.G. and Lysaght, J., PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma, Scientific Reports, 12, (1), 2022,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Davern, M. and Donlon, N.E. and Oâ Connell, F. and Sheppard, A.D. and Hayes, C. and King, R. and Temperley, H. and Butler, C. and Bhardwaj, A. and Moore, J. and Bracken-Clarke, D. and Donohoe, C. and Ravi, N. and Reynolds, J.V. and Maher, S.G. and Conroy, M.J. and Lysaght, J., Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma, Translational Oncology, 20, (101406), 2022,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
McGrath, J. and Kane, L.E. and Maher, S.G., The Influence of MicroRNA-31 on Oxidative Stress and Radiosensitivity in Pancreatic Ductal Adenocarcinoma, Cells, 11, (15), 2022,
Notes: [cited By 1],
Journal Article,
PUBLISHED
DOI
|
Donlon NE, Davern M, O'Connell F, Sheppard A, Heeran A, Bhardwaj A, Butler C, Narayanasamy R, Donohoe C, Phelan JJ, Lynam-Lennon N, Dunne MR, Maher S, O'Sullivan J, Reynolds JV, Lysaght J., Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma, World Journal of Gastroenterology, 2022,
Journal Article,
PUBLISHED
|
Davern M, Donlon NE, Sheppard AS, Majcher KD, Connell FO, Heeran AB, Grant M, Farrell RA, Hayes C, Bracken-Clarke D, Conroy MJ, Foley E, Toole DO, Bhardwaj A, Ravi N, Reynolds JV, Maher SG, Sullivan JO, Lysaght J., FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy, Journal of Cancer Research and Clinical Oncology, 2022,
Journal Article,
PUBLISHED
URL
|
Edge SD, Renard I, Pyne E, Li C, Moody H, Roy R, Beavis AW, Archibald SJ, Cawthorne CJ, Maher SG, Pires IM., PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma., The British journal of radiology, 94, (1119), 2021, p20201191 ,
Journal Article,
PUBLISHED
DOI
|
|